HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls

Infection and Immunity

Volumn 73, Issue 9, 2005, Pages 5799-5808

  Lyke, Kirsten E ^a   Burges, Robin B ^a   Cissoko, Yacouba ^b   Sangare, Lansana ^b   Kone, Abdoulaye ^b   Dao, Modibo ^b   Diarra, Issa ^b   Fernández Viňa, Marcelo A ^c   Plowe, Christopher V ^a   Doumbo, Ogobara K ^b   Sztein, Marcelo B ^a,d  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CIRCUMSPOROZOITE PROTEIN; EPITOPE; EXPORT PROTEIN 1; GAMMA INTERFERON; HLA A2 ANTIGEN; PEPTIDE DERIVATIVE; THROMBOSPONDIN; THROMBOSPONDIN RELATED ANONYMOUS PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; AFRICA; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA TYPING; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFANT; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALARIA; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TARGET CELL;

ADOLESCENT; ALLELES; ANIMALS; ANTIGEN PRESENTATION; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; ERYTHROCYTES; HISTOCOMPATIBILITY TESTING; HLA-A2 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MALARIA, FALCIPARUM; MALI; PLASMODIUM FALCIPARUM; SEVERITY OF ILLNESS INDEX;

EID: 23944471718     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.9.5799-5808.2005     Document Type: Article

References (38)

1. Aidoo, M., A. Lalvani, C. E. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, and D. A. Fidock. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345:1003-1007.
2. Aidoo, M., A. Lalvani, S. C. Gilbert, J. T. Hu, P. Daubersies, N. Hurt, H. C. Whittle, P. Druihle, and A. V. Hill. 2000. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect. Immun. 68:227-232.
3. Blum-Tirouvanziam, U., C. Servis, A. Habluetzel, D. Valmori, Y. Men, F. Esposito, L. Del Nero, N. Holmes, N. Fasel, and G. Corradin. 1995. Localization of HLA-A2. 1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J. Immunol. 154:3922-3931.
4. Brasseur, P., M. Agrapart, J. J. Ballet, P. Druilhe, M. J. Warrell, and S. Tharavany. 1983. Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitemia and cerebral malaria. Clin. Immunol. Immunopathol. 27:38-50.
5. Cao, K., M. Chopek, and M. A. Fernandez-Vina. 1999. High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev7 Immunogenet. 1:177-208.
6. Cao, K., J. Hollenbach, X. Shi, W. Shi, M. Chopek, and M. A. Fernandez-Vina. 2001. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol. 62:1009-1030.
7. Cao, K., A. M. Moormann, K. E. Lyke, C. Masaberg, O. P. Sumba, O. K. Doumbo, D. Koech, A. Lancaster, M. Nelson, D. Meyer, R. Single, R. J. Hartzman, C. V. Plowe, J. Kazura, D. L. Mann, M. B. Sztein, G. Thomson, and M. A. Fernandez-Vina. 2004. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63:293-325.
8. Clyde, D. F., V. C. McCarthy, R. M. Miller, and R. B. Hornick. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:398-403.
9. Coulibaly, D., D. A. Diallo, M. A. Thera, A. Dicko, A. B. Guindo, A. K. Kone, Y. Cissoko, S. Coulibaly, A. Djimde, K. Lyke, O. K. Doumbo, and C. V. Plowe. 2002. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am. J. Trop. Med. Hyg. 67:604-610.
10. del Guercio, M. F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685-693.
11. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-1462.
12. Doolan, D. L., S. L. Hoffman, S. Southwood, P. A. Wenrworth, J. Sidney, R. W. Chesnut, E. Keogh, E. Appella, T. B. Nutman, A. A. Lal, D. M. Gordon, A. Oloo, and A. Sette. 1997. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7:97-112.
13. Flanagan, K. L., E. A. Lee, M. B. Gravenor, W. H. Reece, B. C. Urban, T. Doherry, K. A. Bojang, M. Finder, A. V. Hill, and M. Plebanski. 2001. Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. J. Immunol. 167:4729-4737.
14. Flanagan, K. L., T. Mwangi, M. Plebanski, K. Odhiambo, A. Ross, E. Sheu, M. Kortok, B. Lowe, K. Marsh, and A. V. Hill. 2003. Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection. Am. J. Trop. Med. Hyg. 68:421-430.
15. + T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-γ ELISPOT. Parasite Immunol. 22:503-514.
16. Good, M. F., D. Pombo, I. A. Quakyi, E. M. Riley, R. A. Houghten, A. Menon, D. W. Ailing, J. A. Berzofsky, and L. H. Miller. 1988. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immuno-dominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA 85:1199-1203.
17. Hill, A. V., J. Elvin, A. C. Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, and A. R. Townsend. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
18. Hoffman, S. L., C. N. Oster, C. Mason, J. C. Beier, J. A. Sherwood, W. R. Ballou, M. Mugambi, and J. D. Chulay. 1989. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J. Immunol. 142:1299-1303.
19. Lalvani, A., N. Hurt, M. Aidoo, P. Kibatala, M. Tanner, and A. V. Hill. 1996. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur. J. Immunol. 26:773-779.
20. Malik, A., J. E. Egan, R. A. Houghten, J. C. Sadoff, and S. L. Hoffman. 1991. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 88:3300-3304.
21. Nussenzweig, R. S., J. Vanderberg, H. Most, and C. Orton. 1967. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216:160-162.
22. Ott, P. A., B. R. Berner, B. A. Herzog, R. Guerkov, N. L. Yonkers, I. Durinovic-Bello, M. Tary-Lehmann, P. V. Lehmann, and D. D. Anthony. 2004. CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases. J. Immunol. Methods 285:223-235.
23. Pasetti, M. F., R. J. Anderson, F. R. Noriega, M. M. Levine, and M. B. Sztein. 1999. Attenuated ΔguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin. Immunol. 92:76-89.
24. Plebanski, M., M. Aidoo, H. C. Whittle, and A. V. Hill. 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in west Africa. J. Immunol. 158:2849-2855.
25. + T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10:406-410.
26. Rieckmann, K. H., R. L. Beaudoin, J. S. Cassells, and K. W. Sell. 1979. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria, Bull. W. H. O. 57(Suppl. 1):261-265.
27. Riley, E. M., S. J. Allen, S. Bennett, P. J. Thomas, A. O'Donnell, S. W. Lindsay, M. F. Good, and B. M. Greenwood. 1990. Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. Trans. R. Soc. Trop. Med. Hyg. 84:648-657.
28. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schonfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321-337.
29. + effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169:2196-2203.
30. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozo-ite protein. J. Immunol. 149:966-971.
31. Sidney, J., S. Southwood, D. L. Mann, M. A. Fernandez-Vina, M. J. Newman, and A. Sette. 2001. Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum. Immunol. 62:1200-1216.
32. Tacket, C. O., M. B. Sztein, S. S. Wasserman, G. Losonsky, K. L. Kotloff, T. L. Wyant, J. P. Nataro, R. Edelman, J. Perry, P. Bedford, D. Brown, S. Chatfield, G. Dougan, and M. M. Levine. 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 68:1196-1201.
33. Troye-Blomberg, M., E. M. Riley, L. Kabilan, M. Holmberg, H. Perlmann, U. Andersson, C. H. Heusser, and P. Perlmann. 1990. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc. Natl. Acad. Sci. USA 87:5484-5488.
34. + memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 161:5284-5295.
35. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, W. R. Weiss, M. Sedegah, C. de Taisne, J. A. Norman, and S. L. Hoffman. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282:476-480.
36. Weiss, W. R., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763-773.
37. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766-775.
38. World Health Organization Communicable Diseases Cluster. 2000. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1):S1-90.